ImportRefusal LogoImportRefusal

CANLAB RESEARCH

⚠️ High Risk

FEI: 3017270789 • Laval, QC • CANADA

FEI

FEI Number

3017270789

📍

Location

Laval, QC

🇨🇦

Country

CANADA
🏢

Address

1555 Boul De Lavenir Su, , Laval, QC, Canada

High Risk

FDA Import Risk Assessment

62.1
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

27
Total Refusals
10
Unique Violations
7/20/2022
Latest Refusal
10/19/2020
Earliest Refusal

Score Breakdown

Violation Severity
75.1×40%
Refusal Volume
53.6×30%
Recency
30.1×20%
Frequency
100.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7524×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32802×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

38621×

DIETARYING

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(A) of the FD&C Act in that the dietary supplement label or labeling fails to list the name of each dietary ingredient of the supplement and the quantity of each such dietary ingredient or , with respect to a proprietary blend of such dietary ingredients, the total quantity of all dietary ingredients in the blend.

38641×

NCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

22801×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

Refusal History

DateProductViolationsDivision
7/20/2022
88PPMGENERAL PURPOSE REAGENT
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
7/7/2022
56FYY99PEPTIDE N.E.C.
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/30/2022
75NBCTEST, NATRIURETIC PEPTIDE
508NO 510(K)
Division of Southeast Imports (DSEI)
6/30/2022
57VL99IN-VITRO DIAG PRODUCTS, N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/30/2022
56FYY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/23/2022
66VDZ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/17/2022
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/10/2022
56FIY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/6/2022
56FIZ99PEPTIDE N.E.C.
118NOT LISTED
2280DIRSEXMPT
333LACKS FIRM
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/2/2022
56FYY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/29/2021
56FAY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
12/13/2021
56FAY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2021
65FIY05WATER, FOR INJECTION, BACTERIOSTATIC, U.S.P. (PHARMACEUTIC AID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/23/2021
56FIY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/17/2021
56FDY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
56FIY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
56YIY99ANTIBIOTIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/26/2021
56FIY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/26/2021
56FIY99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/6/2021
56FIT99PEPTIDE N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
10/19/2020
54FYL99HERBALS & BOTANICALS (NOT TEAS), N.E.C.
2300DIETARYLBL
320LACKS FIRM
3862DIETARYING
3864NCONTACT
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is CANLAB RESEARCH's FDA import refusal history?

CANLAB RESEARCH (FEI: 3017270789) has 27 FDA import refusal record(s) in our database, spanning from 10/19/2020 to 7/20/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CANLAB RESEARCH's FEI number is 3017270789.

What types of violations has CANLAB RESEARCH received?

CANLAB RESEARCH has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about CANLAB RESEARCH come from?

All FDA import refusal data for CANLAB RESEARCH is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.